ETS1 plays a crucial role in VEGFA-induced angiogenesis 46,47
MSs may have a malignant clinical course even in the absence of histologic criteria of malignancy
It can promote cell death by reducing intracellular GSH levels, although in some cases, it may contribute to cancer progression depending on its interactions with stress-related cellular mechanisms (Zhang et al., 2024)
The potential impact of background therapy in the PIONEER trials is an important consideration
Semax and selank, often used in nasal spray formulations , follow standard storage guidelines when reconstituted for injection use
A degraded peptide may not activate GLP-1 receptors as intended, leading to inadequate metabolic effect and wasted medication cost